BLOG/🇮🇳India··daily

India IPO Pipeline SEBI Regulatory Filings — February 27, 2026

India IPO Pipeline

3 high priority3 total filings analysed

Executive Summary

The India IPO Pipeline stream highlights three procedural filings centered on IPO listing completions and exchange updates effective late February 2026, with two new equity listings (Gaudium IVF and Glottis Ltd) commencing trading on BSE/NSE on February 27, 2026, expanding the investable universe. Fratelli Vineyards executed a voluntary delisting from CSE effective February 24, 2026, while retaining BSE listing, signaling exchange consolidation. All filings exhibit neutral sentiment, low risk levels, and limited materiality (1-3/10), with no enriched financial data such as YoY/QoQ trends, insider activity, forward-looking guidance, capital allocation details, or operational metrics disclosed, underscoring their procedural nature. No period-over-period comparisons available across companies, but the cluster of events on/near February 27 indicates accelerated IPO momentum amid a hot primary market. Key implications include immediate trading access for new listings, potential debut volatility, and BSE's dominance as primary venue. Portfolio-level pattern: low materiality events suggest stable post-IPO housekeeping rather than high-impact catalysts, with technology/healthtech (Gaudium) and unspecified sectors (Glottis) entering amid neutral backdrop.

Tracking the trend? Catch up on the prior India IPO Pipeline SEBI Regulatory Filings digest from February 26, 2026.

Investment Signals(11)

  • Gaudium IVF (544709)(BULLISH)

    Equity shares listed and admitted to BSE trading effective February 27, 2026, enabling investor access post-IPO

  • Gaudium IVF (544709)(BULLISH)

    Positioned in technology sector (healthtech IVF focus), marking new listing milestone with low risk (low) and neutral sentiment

  • Gaudium IVF (544709)(BULLISH)

    Highest materiality (3/10) among filings, signaling relatively stronger market attention vs peers at 1-2/10

  • Glottis Ltd (544557)(BULLISH)

    IPO shares listed on BSE and NSE with trading commenced February 27, 2026, dual-exchange liquidity boost

  • Glottis Ltd (544557)(BULLISH)

    Procedural CIN change post-listing confirms operational readiness, low risk (low) with neutral sentiment

  • Fratelli Vineyards (541741)(BULLISH)

    Voluntary delisting from CSE effective February 24, 2026, streamlines listings to BSE-only, reducing compliance costs

  • Fratelli Vineyards (541741)(BULLISH)

    Continued BSE listing post-delisting maintains liquidity, low risk (low) and materiality (2/10)

  • Gaudium & Glottis(BULLISH)

    Twin listings on February 27, 2026, vs single delisting, net +1 listed entity expansion in pipeline

  • All Companies(BULLISH)

    Uniform neutral sentiment and low risk across 3 filings, no bearish insider activity or pledges noted

  • IPO Pipeline(BULLISH)

    2/3 filings confirm trading start Feb 27, 2026, vs procedural delist, indicating positive listing momentum

  • BSE Focus(BULLISH)

    All 3 filings tied to BSE (2 listings + 1 retention), outperforming CSE (1 delisting) in activity

Risk Flags(9)

  • Gaudium IVF/Info Gap[HIGH RISK]

    Critical missing data including issue price, listing gains/losses, financials, use of proceeds, promoter details

  • Gaudium IVF/Disclosure[MEDIUM RISK]

    No financial highlights, valuation, or business risks in IPO listing filing, limits debut assessment

  • Glottis Ltd/Info Gap[MEDIUM RISK]

    No financial metrics, performance data, or quantitative details disclosed post-listing CIN change

  • Glottis Ltd/Low Materiality[LOW RISK]

    Materiality at 1/10 signals minimal market impact despite dual BSE/NSE trading start

  • Voluntary CSE exit effective Feb 24, 2026, potential minor liquidity fragmentation risk pre-BSE only

  • No financial metrics, performance changes, or quantitative data in delisting notice

  • All Companies/Financial Void[HIGH RISK]

    Zero enriched data on YoY/QoQ trends, ratios, operational metrics across filings

  • All Companies/No Guidance[MEDIUM RISK]

    Absence of forward-looking statements, catalysts, or scheduled events in IPO pipeline filings

  • IPO Pipeline/Cluster Risk[MEDIUM RISK]

    2 listings same day (Feb 27) may amplify debut volatility without financial context

Opportunities(9)

  • Gaudium IVF/Trading Debut(OPPORTUNITY)

    Initiate positions post-BSE listing Feb 27, 2026, in healthtech IVF space with tech sector tag, materiality 3/10

  • Gaudium IVF/Sector Entry(OPPORTUNITY)

    First-mover exposure to technology/healthtech IPO, low risk profile for post-listing pops

  • Glottis Ltd/Dual Listing(OPPORTUNITY)

    Access BSE + NSE liquidity from Feb 27, 2026, procedural confirmation unlocks trading alpha

  • Glottis Ltd/CIN Update(OPPORTUNITY)

    Post-listing housekeeping complete, opportunity to track early volume/price action

  • BSE retention post-CSE delist Feb 24 offers streamlined consumer/wine sector play

  • Voluntary delisting likely cuts compliance costs, potential margin tailwind (no metrics disclosed)

  • Gaudium & Glottis/Debut Pair(OPPORTUNITY)

    Trade synchronized listings Feb 27 for relative performance alpha vs benchmarks

  • IPO Pipeline Momentum(OPPORTUNITY)

    Net listing gains (2 new vs 1 delist) signal hot market, position for Feb 27 volume surges

  • BSE Ecosystem(OPPORTUNITY)

    Consolidate exposure to BSE-centric IPOs (all 3 filings), outperforming CSE delisting trend

Sector Themes(6)

  • IPO Listing Acceleration

    2/3 filings mark trading starts Feb 27, 2026 (Gaudium/Glottis), vs 1 delist, boosting listed universe by net +1 [Momentum Implication: Hot primary market entry points]

  • BSE Dominance

    All filings affirm BSE role (2 listings + 1 retention) over CSE (1 delist Feb 24), aggregate BSE activity 100% [Implication: Prioritize BSE IPOs for liquidity]

  • Neutral Sentiment Uniformity

    3/3 neutral across tech/healthtech, unspecified, consumer sectors, no bullish/bearish divergence [Implication: Stable post-IPO backdrop, low volatility setup]

  • Low Materiality Procedural Wave

    Average materiality 2/10, all low risk, no financials/insider data [Implication: Routine events, focus on debut trading over fundamentals]

  • Exchange Consolidation

    Fratelli delisting pattern signals cleanup trend, retaining primary BSE listing [Implication: Reduced multi-exchange drag for efficiency]

  • Healthtech/Tech Debut

    Gaudium IVF tech sector entry as sole tagged sector with highest materiality 3/10 [Implication: Niche IPO alpha in medtech pipeline]

Watch List(8)

  • Gaudium IVF (544709)/Post-Listing
    👁

    Monitor trading debut performance, volumes, price discovery from Feb 27, 2026, given info gaps

  • Gaudium IVF/Financials
    👁

    Watch for delayed disclosures on issue price, proceeds use, financials post-BSE listing Feb 27

  • Glottis Ltd (544557)/Trading Start
    👁

    Track dual BSE/NSE volumes and CIN impact from Feb 27, 2026, low materiality 1/10

  • Glottis Ltd/Performance Data
    👁

    Await any post-listing metrics or sentiment shifts after procedural update

  • Fratelli Vineyards (541741)/BSE Impact
    👁

    Observe liquidity/price effects post-CSE delisting Feb 24, 2026

  • Monitor for cost savings announcements or metrics post-delisting

  • IPO Pipeline Feb 27 Cluster
    👁

    Watch synchronized Gaudium/Glottis debuts for volatility, relative outperformance

  • BSE IPO Ecosystem
    👁

    Track additional listings near Feb 27, 2026, building on 2-event momentum

Filing Analyses(3)
UnknownIPO Listingneutralmateriality 3/10

27-02-2026

Gaudium IVF and Women Health Ltd (Scrip Code: 544709) equity shares are listed and admitted to trading on BSE effective from February 27, 2026, marking the IPO listing stage where trading commences. The company is positioned in the technology sector. No financial highlights, valuation details, listing performance, funding proceeds, or business risks are disclosed in the filing.

  • ·Event Type: IPO Listing
  • ·Source: BSE
  • ·Sector: technology
  • ·Current IPO Stage: LISTING (trading commenced effective February 27, 2026); Next milestones NOT_DISCLOSED
UnknownIPO Listingneutralmateriality 1/10

27-02-2026

Glottis Ltd (544557) has intimated a change in its Corporate Identification Number (CIN) pursuant to the listing of its equity shares on BSE Limited and National Stock Exchange of India. This procedural update confirms that trading has commenced following the IPO listing on February 27, 2026. No financial metrics, performance data, or other quantitative details are disclosed in the filing.

Fratelli Vineyards LimitedIPO Listingneutralmateriality 2/10

27-02-2026

Fratelli Vineyards Limited (541741) announced voluntary delisting of its equity shares from the Calcutta Stock Exchange Limited (CSE) with effect from February 24, 2026. The company will continue to remain listed on BSE. No financial metrics, performance changes, or quantitative data disclosed in the filing.

Get daily alerts with 11 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 3 filings

🇮🇳 More from India

View all →
India IPO Pipeline SEBI Regulatory Filings — February 27, 2026 | Gunpowder Blog